the antihypertensive effects of orally administered cd-349 , ( 2-nitratopropyl-3-nitratopropyl-2,6-dimethyl-4- ( 3-nitrophen yl ) - 1,4-dihydropyridine-3,5-dicarboxylate ) , a new dihydropyridine calcium-entry blocker , were evaluated in comparison with nifedipine in spontaneously hypertensive rats ( shr ) , renal hypertensive rats ( rhr ) and normotensive rats ( ntr ) all in a conscious state .
C0012315
dihydropyridine
C0028066
nifedipine